Has Meyer Gershbaum, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,901 in general payments to Meyer Gershbaum, MD across 42 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Meyer Gershbaum, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Meyer Gershbaum, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Meyer Gershbaum, MD

Urology · Flushing, NYNPI 1033108220

Payments from drug & device makers

$7,901in general payments, 2019–2025

Across 42 payments — averaging $188.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$5K
Procept Biorobotics Corporation$2K
Boston Scientific$178
Coloplast$146
Urogen Pharma, Inc.$93
Astellas Pharma US Inc$80
plus $358 from 9 others

What the payments were for

Travel & lodging$2,93837%
Food & beverage$85611%
Education$4,10752%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	6	$5,256
Procept Biorobotics Corporation	9	$1,792
Boston Scientific	5	$178
Coloplast	2	$146
Urogen Pharma, Inc.	3	$93
Astellas Pharma US Inc	1	$80
Axonics, Inc.	2	$75
Bayer	3	$68
Progenics Pharmaceuticals, Inc.	2	$44
Myriad Genetic Laboratories, Inc.	2	$37
Pfizer	2	$32
AbbVie(2 entities)	2	$32
Johnson & Johnson	1	$26
Sumitomo Pharma America, Inc.	1	$23
Vertex	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,901 in reported general payments places this provider in the 70th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024

$63,453

Medicare patients

211

Services billed

474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dutasteride	38	$1,447
Tamsulosin Hcl	62	$1,383
Finasteride	20	$238
Cefadroxil	43	$96
Levofloxacin	13	$44
Ciprofloxacin Hcl	15	$33

Paid to pharmacies, not to this prescriber.

Other urology in Flushing

James WysockFlushing$231K
Christopher PieczonkaSyracuse$31.2M
Guarionex DecastroNew York$5.7M
Mitchell EfrosGarden City$4.2M
James McKiernanNew York$4.1M
William HuangNew York$3.9M
Jed KaminetskyMiddle Village$3.5M
Evan GoldfischerPoughkeepsie$3.1M
Gennady BratslavskySyracuse$2.5M
Ashutosh TewariNew York$2.5M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →